Arintra, a medical coding platform, has raised $21 million in a Series A funding round led by Peak XV Partners.
Other investors in the round include Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13, and several strategic backers.
The funding will be used to expand Arintra’s use in U.S. health systems and physician groups, speed up product development, grow the team, and open a new headquarters in the Bay Area.
“At Arintra, we bring together autonomous medical coding, clinical documentation improvement, and denial prevention in a single platform. By helping providers document what was done, code what was documented, and properly support what was charged, we enable them to secure full, compliant reimbursement at a lower cost, with fewer delays and significantly less manual effort,” said Preeti Bhargava, Co-founder and CTO of Arintra.
“The disruption of the $150 billion healthcare reimbursement industry will be one of AI’s defining impacts. Arintra’s autonomous system tackles one of the hardest challenges for providers: translating clinical documentation into accurate insurance codes so they get paid fairly and fast. The results speak for themselves; providers are recovering millions in lost revenue by partnering with Arintra,” said Mohit Bhatnagar, MD, Peak XV.
Founded in 2020 by Nitesh Shroff and Preeti Bhargava, Arintra provides a GenAI-powered autonomous medical coding platform for healthcare providers.
The platform automates the conversion of clinical documentation into accurate insurance codes and combines clinical documentation improvement (CDI) and denials prevention in one system.
Arintra’s platform helps healthcare providers get complete, compliant reimbursements while reducing costs, improving claim accuracy, and speeding up payments.
As an enterprise SaaS, it connects with EHR systems like Epic and Athena, working smoothly within existing workflows.
Read more- Diginex to Acquire Israeli Cyber Firm Findings in $305M Deal
